TipRanks
pc:norgi

Norgine

Norgine B.V. Antonio Vivaldistraat 150 Amsterdam, Amsterdam 1083 HP, NL
https://www.norgine.com/
Norgine is a European specialty pharmaceutical company focused on the development, manufacturing and commercialization of medicines for gastroenterology and other specialty therapeutic areas. The company operates manufacturing sites across Europe and supplies medicines across the UK and Europe, emphasizing reliable supply, manufacturing innovation, and quality control.

Leadership & Board

Current Number of Employees1,176
Current LinkedIn Followers92,030

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$23M
Total Amount Raised$23M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$23M
Latest Funding Amount$23M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Employee Trend

Norgine had 1,176 employees as of September 14, 2026. The number of employees increased by 4 (0.34%) week-over-week.
1,176Latest Employee Count
4(0.34%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Norgine had 92,030 followers as of September 14, 2026. The number of followers increased by 261 (0.28%) week-over-week.
92,030Latest Followers Count
261(0.28%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Mar 05, 2026
Investment
$23.00M

Investors

Similar Companies

A snapshot of private companies similar to Norgine, helping you discover and navigate related company profiles.

Related News and Analysis